BSE May File Draft IPO Prospectus Next Month; Hires Edelweiss as Lead Banker
 in Mumbai, India.jpg?downsize=1010:568 "BSE May File Draft IPO Prospectus Next Month; Hires Edelweiss as Lead Banker")
Leading bourse BSE is targeting to file draft papers with capital markets regulator SEBI for its much-awaited initial public offer by early next month.BSE is looking to raise about Rs 800 crore from its initial share-sale programme, which is expected to be entirely an offer for sale.
As per sources, the exchange plans to file IPO papers with SEBI in early September to mop-up around Rs 800 crore.As many as three crore shares are estimated to have been tendered by the BSE shareholders for the offer for sale in the proposed IPO, earlier this week.The exchange has set up an escrow account wherein shareholders can tender shares for the OFS in the proposed IPO. Asia's oldest bourse, which earlier this year received in-principle approval from markets regulator to list its shares, plans to sell up to 30 percent stake in IPO.
A maximum of 30 percent of BSE's equity can be diluted through the OFS. As on date, the exchange has about 9,283 shareholders comprising brokers and institutions.BSE (earlier known as the Bombay Stock Exchange) has appointed Edelweiss Financial Services as the lead merchant banker and AZB & Partners and Nishith Desai Associates as legal advisors to the IPO.The exchange had reported a 40 percent increase in its consolidated net profit at Rs 52.72 crore for the first quarter ended June 2016.
The Securities and Exchange Board of India notified amendments to the Stock Exchanges and Clearing Corporations regulations on January 1. The new rules are aimed at making it easier for stock exchanges to list their shares through an IPO.
Soon after the amendments, the exchange had sought approval for launching the IPO, saying it is in compliance with all the requirements for listing.Presently, Multi Commodity Exchange of India is the only listed bourse in the country.BSE's closest competitor NSE also plans to file for listing next year.
Also Read: NSE Appoints Four Bankers for its IPO, Investors Eye Listing by March 2017
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.
